Literature DB >> 26773719

Association of aerobic fitness level with exercise-induced hypoglycaemia in Type 1 diabetes.

R A Al Khalifah1,2, C Suppère3, A Haidar3,4, R Rabasa-Lhoret3,4,5,6, M Ladouceur7, L Legault1.   

Abstract

AIM: To determine the impact of physical fitness level on hypoglycaemia risk during exercise in people with Type 1 diabetes.
METHODS: A total of 44 patients [34 adults (aged 22-70 years) and 10 adolescents (aged 12-18 years)] with Type 1 diabetes, treated with insulin pump therapy, underwent a standardized exercise session. Cardiorespiratory fitness (maximum oxygen uptake) was measured and classified, based on established norms for age and sex, into either poor (< 25th percentile) or good fitness level (> 25th percentile). Plasma glucose levels were measured every 10 min, each patient performed physical activity at 60% maximum oxygen uptake either on a treadmill for 1 h or on a bicycle for 30 min. Frequency of hypoglycaemia (plasma glucose < 4 mmol/l) and decline in plasma glucose levels during exercise were assessed.
RESULTS: In all, 23 patients had a good exercise fitness level. Hypoglycaemic events occurred in 17/23 patients (74.0%) in the good fitness level group compared with 8/21 patients (38.0%) in the poor fitness level group (P = 0.02). Both groups had similar pre-exercise plasma glucose levels. The plasma glucose values during exercise in the good fitness level group compared with the poor fitness level group were: plasma glucose nadir 3.9 ± 1.6 vs 5.5 ± 2.4 mmol/l (P = 0.01) and plasma glucose change -4.6 ± 3.4 vs. -2.1 ± 3.1 mmol/l (P = 0.01). The correlation between the plasma glucose nadir and maximum oxygen uptake was r = -0.38 (P = 0.01).
CONCLUSIONS: Patients with good fitness level seem to be more prone to hypoglycaemia during exercise. This could be the result of better insulin sensitivity and the fact that they tend to exercise at greater work thresholds. These results are a step toward a better understanding of the association between physical fitness and exercise-induced hypoglycaemia.
© 2016 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26773719     DOI: 10.1111/dme.13070

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  11 in total

1.  The Effects of Basal Insulin Suspension at the Start of Exercise on Blood Glucose Levels During Continuous Versus Circuit-Based Exercise in Individuals with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion.

Authors:  Dessi Zaharieva; Loren Yavelberg; Veronica Jamnik; Ali Cinar; Kamuran Turksoy; Michael C Riddell
Journal:  Diabetes Technol Ther       Date:  2017-06       Impact factor: 6.118

2.  Glucose management for exercise using continuous glucose monitoring: should sex and prandial state be additional considerations?

Authors:  Jane E Yardley; Ronald J Sigal
Journal:  Diabetologia       Date:  2021-01-07       Impact factor: 10.122

Review 3.  Biopsychosocial Aspects of Weight Management in Type 1 Diabetes: a Review and Next Steps.

Authors:  Kimberly A Driscoll; Karen D Corbin; David M Maahs; Richard Pratley; Franziska K Bishop; Anna Kahkoska; Korey K Hood; Elizabeth Mayer-Davis
Journal:  Curr Diab Rep       Date:  2017-08       Impact factor: 4.810

4.  The Bhubaneswar Declaration on Sports Endocrinology, 2018.

Authors:  Sanjay Kalra; Abhay Sahoo; Sambit Das; K V S Hari Kumar; Anoj Kumar Baliarsinha; Binoy Mohanty; Jayabhanu Kanwar; Sunil Kota; Sudeep Satpathy; Muthukrishnan Jayaraman; S K Singh; S V Madhu; Mona Shah; Narendra Kotwal; Gagan Priya; Belinda George; Arundhati Dasgupta; Arun Kumar R Pande; Nikhil Latey; Puneet Dhamija; John Ayuk; David Torpy; Pankaj Shah; Mohammed Wali Naseri; Robin Maskey; Zafar A Latif; Noel Somasundaram; Ali Jawa; Kirtida Acharya
Journal:  Indian J Endocrinol Metab       Date:  2018-11

Review 5.  Could Age, Sex and Physical Fitness Affect Blood Glucose Responses to Exercise in Type 1 Diabetes?

Authors:  Jane E Yardley; Nicole K Brockman; Richard M Bracken
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-15       Impact factor: 5.555

6.  Developing "Aryan:" Diabetes Self-care Mobile Application.

Authors:  Maryam Jahanbakhsh; Asghar Ehteshami; Shekoufeh Afkhami
Journal:  Int J Prev Med       Date:  2019-05-06

Review 7.  Diabetic Cardiomyopathy and Ischemic Heart Disease: Prevention and Therapy by Exercise and Conditioning.

Authors:  Antonio Crisafulli; Pasquale Pagliaro; Silvana Roberto; Lucia Cugusi; Giuseppe Mercuro; Antigone Lazou; Christophe Beauloye; Luc Bertrand; Derek J Hausenloy; Manuela Aragno; Claudia Penna
Journal:  Int J Mol Sci       Date:  2020-04-21       Impact factor: 5.923

8.  Modelling glucose dynamics during moderate exercise in individuals with type 1 diabetes.

Authors:  Haneen Alkhateeb; Anas El Fathi; Milad Ghanbari; Ahmad Haidar
Journal:  PLoS One       Date:  2021-03-26       Impact factor: 3.240

9.  Glucose management for exercise using continuous glucose monitoring: should sex and prandial state be additional considerations? Reply to Yardley JE and Sigal RJ [letter].

Authors:  Othmar Moser; Michael C Riddell; Max L Eckstein; Peter Adolfsson; Rémi Rabasa-Lhoret; Louisa van den Boom; Pieter Gillard; Kirsten Nørgaard; Nick S Oliver; Dessi P Zaharieva; Tadej Battelino; Carine de Beaufort; Richard M Bergenstal; Bruce Buckingham; Eda Cengiz; Asma Deeb; Tim Heise; Simon Heller; Aaron J Kowalski; Lalantha Leelarathna; Chantal Mathieu; Christoph Stettler; Martin Tauschmann; Hood Thabit; Emma G Wilmot; Harald Sourij; Carmel E Smart; Peter G Jacobs; Richard M Bracken; Julia K Mader
Journal:  Diabetologia       Date:  2021-02-04       Impact factor: 10.122

10.  Characterization of Individualized Glycemic Excursions during a Standardized Bout of Hypoglycemia-Inducing Exercise and Subsequent Hypoglycemia Treatment-A Pilot Study.

Authors:  Jan Brož; Matthew D Campbell; Jana Urbanová; Marisa A Nunes; Ludmila Brunerová; Dario Rahelić; Denisa Janíčková Žďárská; Arian Taniwall; Marek Brabec; Vojtěch Berka; Juraj Michalec; Jan Polák
Journal:  Nutrients       Date:  2021-11-21       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.